L-Poladdict (Levomethadone Hydrochloride)

Levomethadone is used in opioid dependence management and related therapeutic pathways.

• Opioid dependence: supports maintenance therapy to help patients remain abstinent from illicit opioids.
• Opioid withdrawal: alleviates acute withdrawal symptoms during detoxification.
• Opioid substitution therapy: provides stable mu‑opioid receptor activation as an alternative to other opioids.

• Levomethadone acts as a potent mu‑opioid receptor agonist, binding to the receptor sites in the central nervous system. This activation produces analgesic and euphoric effects while suppressing the craving and withdrawal phenomena associated with opioid dependence. The drug’s high affinity and intrinsic activity result in a controlled, long‑lasting opioid effect that stabilizes patients during maintenance therapy.

Levomethadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: feeling of sickness or urge to vomit.
• Constipation: reduced bowel movements and hard stools.
• Dizziness: light‑headedness or unsteady sensation.
• Sedation: increased sleepiness or drowsiness.
• Sweating: excessive perspiration unrelated to temperature.
• Headache: mild to moderate head pain.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• QT interval prolongation: cardiac electrical disturbance that may lead to arrhythmia.
• Severe hypotension: marked drop in blood pressure causing faintness.
• Cardiac arrhythmia: irregular heart rhythm requiring urgent care.
• Seizures: convulsive episodes in susceptible individuals.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing levomethadone, clinicians should observe several safety measures.

• Assess liver function: evaluate hepatic status before initiating therapy.
• Monitor respiratory status: watch for signs of respiratory depression, especially during dose adjustments.
• Evaluate cardiac QT interval: perform ECG monitoring in patients at risk for QT prolongation.
• Avoid use in severe respiratory depression: contraindicated in patients with compromised breathing.
• Use caution in pregnancy: safety category unknown; weigh benefits against potential risks.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levomethadone can interact with various medications, requiring careful management.

Major Interactions (Avoid)

• Central nervous system depressants: concurrent use with benzodiazepines or barbiturates may cause profound sedation.
• MAO inhibitors: risk of severe hypotension and serotonin syndrome.
• Strong CYP3A4 inhibitors: agents like ketoconazole can increase levomethadone plasma levels.
• Other opioids: additive respiratory depression risk.

Moderate Interactions (Monitor Closely)

• CYP2B6 inducers: drugs such as rifampin may reduce levomethadone effectiveness.
• Alcohol: may enhance sedative effects and respiratory depression.
• Certain antidepressants: may alter opioid metabolism or increase QT prolongation risk.